Testing effectiveness (Phase 2)Study completedNCT00718081
What this trial is testing
A Multicenter, Randomized, Placebo-Controlled Phase 2 Study to Evaluate the Clinical Efficacy, Safety, and Tolerability of ARX-F01 Sublingual Sufentanil in Patients Undergoing Major Abdominal Surgery
Who this might be right for
Major Upper or Lower Abdominal Surgery
Talphera, Inc 88